Company intelligence / Profile preview
Shanghai Zhongyao Biotechnology
Shanghai, Shanghai, Chinazhongyaobio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Zhongyao Biotech is a Shanghai-based biotechnology company specializing in the development of mRNA-based therapeutics and vaccines. The company leverages a proprietary mRNA-LNP (lipid nanoparticle) delivery platform to create next-generation treatments for infectious diseases and oncology. Their research focus includes optimizing mRNA stability and delivery efficiency to improve therapeutic outcomes. Zhongyao Biotech is currently advancing several candidates through the pre-clinical stage, aiming to address unmet medical needs in the global healthcare market.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- mRNA-based drugsLipid nanoparticle delivery therapyVaccine
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Shanghai Zhongyao Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Zhongyao Biotechnology.